Page last updated: 2024-08-23

etoposide and Gastrointestinal Stromal Tumors

etoposide has been researched along with Gastrointestinal Stromal Tumors in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boichuk, S; Dunaev, P; Galembikova, A; Mustafin, I; Valeeva, E1
Cordier, JF; Cottin, V; Girard, N; Lapalus, MG; Tronc, F1

Other Studies

2 other study(ies) available for etoposide and Gastrointestinal Stromal Tumors

ArticleYear
Inhibition of fibroblast growth factor receptor-signaling sensitizes imatinib-resistant gastrointestinal stromal tumors to low doses of topoisomerase II inhibitors.
    Anti-cancer drugs, 2018, Volume: 29, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; DNA Damage; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Neoplasm; Drug Synergism; Etoposide; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Phenylurea Compounds; Pyrimidines; Rad51 Recombinase; Receptors, Fibroblast Growth Factor; Signal Transduction; Topoisomerase II Inhibitors

2018
Synchronous small-cell lung cancer and gastrointestinal stromal tumor: a case report.
    Presse medicale (Paris, France : 1983), 2009, Volume: 38, Issue:1

    Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Doxorubicin; Etoposide; Fatal Outcome; Gastrointestinal Stromal Tumors; Humans; Ifosfamide; Imatinib Mesylate; Lung Neoplasms; Male; Middle Aged; Neoplasms, Multiple Primary; Palliative Care; Piperazines; Pyrimidines; Small Cell Lung Carcinoma; Stomach Neoplasms

2009